Clinical Trials Browser

Phase 2 × OTHER × Uterine Neoplasms × Clear all

NCT05758688 2026-03-12

PROPS GYN

Phase 2 Recruiting

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT06369155 2026-03-02

Azenosertib in Uterine Serous Carcinoma: Biomarker Study

Phase 2 Recruiting

Uterine Neoplasms

NCT03668340 2026-01-12

AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma

Phase 2 Active not recruiting

Uterine Neoplasms

NCT06331468 2025-12-26

Hypofractionated Radiochemotherapy

Phase 2 Recruiting

Uterine Cervical Neoplasms, Uterine Neoplasms

NCT06677190 2025-11-05

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Phase 2 Recruiting

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06492070 2025-08-27

Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers

Phase 2 Recruiting

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

NCT04080284 2025-08-19

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma

Phase 2 Completed

Uterine Neoplasms, Endometrial Neoplasms

NCT05916196 2025-05-08

[18F]FES PET/.CT in Uterine Cancer

Phase 2 Recruiting

Uterine Neoplasms

NCT00087685 2025-05-01

RAD001 in Recurrent Endometrial Cancer Patients

Phase 2 Completed

35 enrolled 6 charts

Uterine Neoplasms, Endometrial Neoplasms

NCT03241745 2024-12-27

A Study of Nivolumab in Selected Uterine Cancer Patients

Phase 2 Completed

35 enrolled 8 charts

GynecologicSarcoma

Carcinosarcoma, Leiomyosarcoma, Uterine Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT03924466 2024-02-16

VUBAR

Phase 2 Unknown

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06180733 2023-12-22

PAM-II

Phase 2 Recruiting

GynecologicLymphoid

Lymphoma, Follicular, Uterine Neoplasms, Endometrial Neoplasms

NCT03302156 2023-09-05

PSMA PET and MRI in Gynecological Cancers

Phase 2 Terminated

15 enrolled 7 charts

Ovarian Neoplasms, Uterine Neoplasms

NCT04066894 2023-08-14

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

Phase 2 Terminated

3 enrolled 5 charts

GastrointestinalGenitourinaryGynecologic

Low Anterior Resection Syndrome, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT01399658 2023-03-14

AMIGO

Phase 2 Completed

93 enrolled 5 charts

Uterine Cervical Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT04398446 2022-09-01

Coala-T-CBD

Phase 2 Unknown

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

NCT03192059 2021-09-08

PRIMMO

Phase 2 Completed

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT00582205 2021-05-19

Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

Phase 2 Terminated

21 enrolled 7 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT03951415 2021-04-01

DOMEC

Phase 2 Unknown

Uterine Neoplasms, Endometrial Neoplasms

NCT02725489 2021-01-27

Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers

Phase 2 Completed

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT00231868 2020-08-12

A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma

Phase 2 Completed

81 enrolled 4 charts

Uterine Neoplasms

NCT04239443 2020-01-27

Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Phase 2 Unknown

GynecologicSarcoma

Sarcoma, Uterine Neoplasms

NCT02349958 2019-04-16

HIPEC/IPHC

Phase 2 Unknown

GastrointestinalGynecologicOther solid neoplasmThoracic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms

NCT00231842 2019-01-23

Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus

Phase 2 Completed

30 enrolled 9 charts

Uterine Neoplasms, Mixed Tumor, Mesodermal

NCT00414076 2018-11-20

Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

Phase 2 Terminated

9 enrolled 7 charts

GynecologicSarcoma

Leiomyosarcoma, Uterine Neoplasms

NCT02454036 2017-12-06

Biobehavioral Intervention in Gynecologic Oncology Patients

Phase 2 Completed

Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT00584857 2017-01-27

A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer

Phase 2 Completed

30 enrolled 8 charts

Uterine Neoplasms

NCT00584909 2017-01-27

A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus

Phase 2 Terminated

13 enrolled 6 charts

Uterine Neoplasms

NCT00502203 2016-05-09

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

Phase 2 Completed

23 enrolled 5 charts

Uterine Neoplasms, Endometrial Neoplasms, Mixed Tumor, Mullerian

NCT00284427 2016-02-10

Safety of Antioxidants During GYN Cancer Care

Phase 2 Completed

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT02095847 2015-04-08

High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection

Phase 2 Withdrawn

Uterine Neoplasms, Endometrial Neoplasms

NCT00282087 2014-12-01

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma

Phase 2 Completed

47 enrolled 16 charts

GynecologicSarcoma

Leiomyosarcoma, Uterine Neoplasms

NCT00626561 2014-07-07

Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix

Phase 2 Terminated

4 enrolled 2 charts

Uterine Cervical Neoplasms, Uterine Neoplasms

NCT01163552 2014-06-13

Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity

Phase 2 Completed

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Ovarian Neoplasms, Thymus Neoplasms, Uterine Neoplasms

NCT00231829 2012-04-24

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

Phase 2 Terminated

Uterine Neoplasms, Adenocarcinoma, Clear Cell

NCT00231855 2012-04-24

Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence, Uterine Neoplasms

NCT00505492 2011-09-15

Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy

Phase 2 Terminated

GynecologicSarcoma

Carcinosarcoma, Uterine Neoplasms

NCT00275353 2006-05-26

Effectiveness of an Individualized Symptom Education Program (ISEP)

Phase 2 Completed

Uterine Cervical Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms